阳性患者结果数的移动和作为质量控制工具
该研究通过数值模拟探讨常规QC对0.03 μg/L小偏倚的检测能力,并评估移动和法作为辅助QC工具的可行性。结果显示最低QC水平(0.86 μg/L)检测该偏倚的概率不足10%,而移动和法显著缩短平均受影响的患者结果数(ANPed)。结论建议实验室补充超低QC水平并采用移动和法辅助QC。
要点
- 常规QC对0.03 μg/L的小偏倚检测概率不足10%,需关注QC策略的敏感性。
- 移动和法检测阳性患者结果数的ANPed显著低于平均值法,可作为辅助QC工具。
- 商业试剂盒最低QC水平不足时,建议使用自配超低QC水平补充。
核心结论
- 常规QC策略可能无法检测0.03 μg/L的小偏倚,移动和法可作为有效的辅助QC工具。
研究设计与样本
- 通过数值模拟评估常规QC、平均值法及移动和法对0.03 μg/L偏倚的检测性能。
主要发现
- 最低QC水平(0.86 μg/L)检测0.03 μg/L偏倚的概率不足10%,不受QC规则影响。
- 平均值法因控制限较宽导致ANPed较高,而移动和法ANPed显著降低。
关键数值与推荐
- 商业试剂盒最低QC水平为0.86 μg/L,对0.03 μg/L偏倚检测概率<10%。
临床怎么用
- 实验室应确保QC策略能检测小但关键的偏倚,必要时补充自配超低QC水平。
- 采用移动和法检测阳性患者结果数作为辅助QC工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, the total prostate-specific antigen (PSA) assay used in a laboratory had a positive bias of 0.03 μg/L, which went undetected. Consequently, a number of post-prostatectomy patients with previously undetectable PSA concentrations (defined as <0.03 μg/L in that laboratory) were being reported as having detectable PSA, which suggested poorer prognosis according to clinical guidelines. METHODS: Through numerical simulations, we explored (1) how a small bias may evade the detection of routine quality control (QC) procedures with specific reference to the concentration of the QC material, (2) whether the use of 'average of normals' approach may detect such a small bias, and (3) describe the use of moving sum of number of patient results with detectable PSA as an adjunct QC procedure. RESULTS: The lowest QC level (0.86 μg/L) available from a commercial kit had poor probability (<10%) of a bias of 0.03 μg/L regardless of QC rule (i.e. 1:2S, 2:2S, 1:3S, 4:1S) used. The average number of patient results affected before error detection (ANPed) was high when using the average of normals approach due to the relatively wide control limits. By contrast, the ANPed was significantly lower for the moving sum of number of patient results with a detectable PSA approach. CONCLUSIONS: Laboratory practitioners should ensure their QC strategy can detect small but critical bias, and may require supplementation of ultra-low QC levels that are not covered by commercial kits with in-house preparations. The use of moving sum of number of patient results with a detectable result is a helpful adjunct QC tool.
引用
- Liu J, Tan CH, Badrick T, et al. Moving sum of number of positive patient result as a quality control tool. Clin Chem Lab Med. 2017. PMID: 28328525. doi:10.1515/cclm-2016-0950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。